A two-fold ambition for Evolucare: international expansion and artificial intelligence
A two-fold ambition for Evolucare: international expansion and Artificial Intelligence. Supported by its new partner, Essling Expansion, Evolucare targets a robust growth both internally and externally. The company is relying on Artificial Intelligence, for instance with its new product OphtAI for the detection of diabetic retinopathy, and international expansion to reach its ambitions.
QBloc and Opesim: Integrated management of outpatient surgery
The development of outpatient surgery is a real step forward in the surgical management of patients, involving significant challenges in terms of information systems. From the programming of resources and post-operative monitoring data to the traceability of all...
Evolucare relies on collaborative innovation to successfully grow to become a medium-sized company
Evolucare, which has been growing for ten years, has revised its strategy for developing new products. Since 2016, Evolucare Labs has been the company’s research and innovation department, showcasing the group’s collaborative projects. Alexandre Le Guilcher, Director...